Total Tests:
Stay in Touch

Get exclusive updates and invitations to our events and webinars:


Your data will stay confidential Private and Confidential

XSS in OneOrZero AIMS

Advisory ID:HTB23066
Product:OneOrZero AIMS
Vendor:www.oneorzero.com ( http://www.oneorzero.com/ )
Vulnerable Versions:2.8.0 Trial build231211 and probably prior
Tested Version:2.8.0 Trial build231211
Advisory Publication:December 28, 2011 [without technical details]
Vendor Notification:December 28, 2011
Public Disclosure:January 18, 2012
Vulnerability Type:Cross-Site Scripting [CWE-79]
CVE Reference:CVE-2012-0989
Risk Level:Medium
CVSSv2 Base Score:4.3 (AV:N/AC:M/Au:N/C:N/I:P/A:N)
Discovered and Provided:High-Tech Bridge Security Research Lab
 

Advisory Details:

High-Tech Bridge SA Security Research Lab has discovered vulnerability in OneOrZero AIMS, which can be exploited to perform cross-site scripting attacks.

1) Cross-site scripting (XSS) vulnerability in OneOrZero AIMS: CVE-2012-0989
Input appended to the URL after index.php is not properly sanitised before being returned to the user.
This can be exploited to execute arbitrary HTML and script code in a user's browser session in context of an affected site
The following PoC code is available:
http://[host]/index.php/%22%3E%3Cscript%3Ealert%28document.cookie%29;%3C/scr ipt%3E
Successful exploitation of this vulnerability requires that victim is logged-in to the vulnerable website and Apache's directive "AcceptPathInfo" is "on" or "default" (default value is "default").

How to Detect Cross-Site Scripting Vulnerabilities
Website Security Test
  • GDPR & PCI DSS Test
  • Website CMS Security Test
  • CSP & HTTP Headers Check
  • WordPress & Drupal Scanning
Try For Free

Solution:
Currently we are not aware of any vendor-supplied patches or other solutions. The vendor was contacted in accordance to our Vendor Notification Policy but we didn't get any answer or feedback.

Have additional information to submit?
Please feel free to send us any additional information related to this Advisory, such as vulnerable versions, additional exploitation details and conditions, patches and other relevant details.
Book a Call Ask a Question
Close
Talk to ImmuniWeb Experts
ImmuniWeb AI Platform
Have a Technical Question?

Our security experts will answer within
one business day. No obligations.

Have a Sales Question?
Email:
Tel: +41 22 560 6800 (Switzerland)
Tel: +1 720 605 9147 (USA)
*
*
*
*
Your data will stay private and confidential